chr2-240630067-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_005301.5(GPR35):āc.115A>Gā(p.Ser39Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,611,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_005301.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR35 | NM_005301.5 | c.115A>G | p.Ser39Gly | missense_variant | 2/2 | ENST00000407714.2 | NP_005292.2 | |
GPR35 | NM_001195381.3 | c.208A>G | p.Ser70Gly | missense_variant | 6/6 | NP_001182310.1 | ||
GPR35 | NM_001195382.3 | c.208A>G | p.Ser70Gly | missense_variant | 6/6 | NP_001182311.1 | ||
GPR35 | NM_001394730.1 | c.208A>G | p.Ser70Gly | missense_variant | 6/6 | NP_001381659.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR35 | ENST00000407714.2 | c.115A>G | p.Ser39Gly | missense_variant | 2/2 | 1 | NM_005301.5 | ENSP00000384263.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249576Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135292
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459662Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 726268
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74342
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 24, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at